Taniqua Andrews
Family · Port St John, FLNPI 1548862998
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,478, more than ten times the $146 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$777
- AbbVie$681
- Lilly USA, LLC$566
- Pfizer$459
- AstraZeneca$369
- Almatica Pharma LLC$359
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,797100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $777 |
| AbbVie | 34 | $681 |
| Lilly USA, LLC | 18 | $566 |
| Pfizer | 24 | $459 |
| AstraZeneca | 17 | $369 |
| Almatica Pharma LLC | 20 | $359 |
| Exact Sciences | 10 | $231 |
| Amgen | 9 | $212 |
| Merck | 10 | $167 |
| Corium, LLC | 8 | $145 |
| GSK | 5 | $93 |
| Antares Pharma, Inc. | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Stimwave Technologies Incorporated | 1 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Eisai Inc. | 1 | $31 |
| Lundbeck LLC | 2 | $30 |
| Halozyme Inc | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| Johnson & Johnson | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Genentech USA, Inc. | 2 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Photonicare Inc | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,797 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Topiramate | 11 | $101 |
Paid to pharmacies, not to this prescriber.
Other family in Port St John
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.